K(
Kun (kevin) Yang
Investor
Beijing
Overview
Kun (Kevin) Yang is a highly experienced professional with over 20 years in the medical industry, specializing in R&D, market strategies, and investment activities. Currently serving as a Partner at GaoRong Capital, he has held key roles at prominent companies such as Medtronic and Biosensors International Group, demonstrating expertise in business development, strategic planning, and market access.
Highlights of Kun (Kevin) Yang's career include serving as the Head of Business Development at Medtronic and holding the position of Senior Director for Business Development & Investment at Biosensors International Group, showcasing his leadership in driving successful commercialization and strategic initiatives within the healthcare sector.
Work Experience
合伙人
2021 - Current
Managing Director
2019 - 2021
Healthcare Team Leader
Partner
2016 - 2019
Healthcare Investment on new drugs, medcial devices, service models, etc.
DT Capital specializes in analyzing, structuring, negotiating, and closing commercial real estate transactions.
Senior Director for Business Development & Investment
2013 - 2016
Invesment and M&A for China business expansion
Head of Business Development
2012 - 2013
Focus on Healthcare Strategy, Business Development, and Investment
Head of Business Development and Strategy
2010 - 2012
Emerging Market Program Manager
2010 - 2010
Focus on M&A, Goverment Policy, and Market Development.
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.
Raised $9,105,978,217.00 from NHS England.
Sr. Product Manager
2008 - 2010
Stratgic Marketing Manager
2007 - 2008
Summer Associate
2006 - 2006
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Raised $28,500,000,000.00 from Citibank and Bank of America.
Gene-chip Manager
2002 - 2005
Research Engineer
1997 - 1999